SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form 8-K - Current report:
SEC Accession No. 0001140361-19-019474
Filing Date
2019-10-31
Accepted
2019-10-31 09:24:24
Documents
12
Period of Report
2019-10-31
Items
Item 1.01: Entry into a Material Definitive Agreement

Document Format Files

Seq Description Document Type Size
1 8-K form8k.htm   iXBRL 8-K 42429
  Complete submission text file 0001140361-19-019474.txt   189574

Data Files

Seq Description Document Type Size
2 XBRL TAXONOMY EXTENSION SCHEMA myov-20191031.xsd EX-101.SCH 4383
3 XBRL TAXONOMY EXTENSION LABEL LINKBASE myov-20191031_lab.xml EX-101.LAB 24319
4 XBRL TAXONOMY EXTENSION PRESENTATION LINKBASE myov-20191031_pre.xml EX-101.PRE 17287
10 EXTRACTED XBRL INSTANCE DOCUMENT form8k_htm.xml XML 4378
Mailing Address SUITE 1, 3RD FLOOR 11-12 ST. JAMES SQUARE LONDON X0 SW1Y 4LB
Business Address SUITE 1, 3RD FLOOR 11-12 ST. JAMES SQUARE LONDON X0 SW1Y 4LB 44(0)207 400 3347
Myovant Sciences Ltd. (Filer) CIK: 0001679082 (see all company filings)

IRS No.: 000000000 | State of Incorp.: CA | Fiscal Year End: 0331
Type: 8-K | Act: 34 | File No.: 001-37929 | Film No.: 191182297
SIC: 2834 Pharmaceutical Preparations